Rohan Palekar - Feb 9, 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role: Chief Executive Officer, Director
Signature: /s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Stock symbol: ETNB
Transactions as of: Feb 9, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/13/2023, 04:42 PM
Previous filing: Feb 7, 2023
Next filing: Feb 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ETNB	Common Stock	Award	$0	+75K	+34.83%	$0.00	290K	Feb 9, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ETNB	Stock Option (Right to Buy)	Award	$0	+300K		$0.00	300K	Feb 9, 2023	Common Stock	300K	$14.70	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units that vest with respect to one-third of the underlying shares on February 9, 2024, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer.
F2	This option represents a right to purchase a total of 300,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 9, 2024, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.